# Cumberland Pharmaceuticals Inc: Form 8-K, filed Dec 7, 2018

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: 8-K
- Filed: 2018-12-07
- Accepted by EDGAR: Dec 7, 2018, 17:13 ET
- Period: 2018-12-07
- Accession: 0001628280-18-014936
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000162828018014936/a8-kgel2ndamendtoassetpurc.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000162828018014936/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000162828018014936/a8-kgel2ndamendtoassetpurc.htm

Filed Dec 7, 2018.
Source: SEC EDGAR, the filing index for accession 0001628280-18-014936. Last ingested by Listed: Nov 11, 2026, 03:05 ET. No prices; not investment advice.
